α-Fodrin-CENP-E interaction is critical for pancreatic cancer progression and drug response
- Athira Jyothy 1,2, Julfequar Hussain 1, Sharanya C S 3, Vineetha Radhakrishnan Chandraprabha 4, Madhumathy G Nair 5, Smreti Vasudevan 6, Hariharan Sreedharan 4, Betty Abraham 7, Tessy Thomas Maliekal 1, Kathiresan Natarajan 3, Suparna Sengupta 1
- Athira Jyothy 1,2, Julfequar Hussain 1, Sharanya C S 3
- 1Department of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
- 2Department of Biotechnology, University of Kerala, Thiruvananthapuram, India.
- 3Transdisciplinary Biology Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
- 4Laboratory of Cytogenetics and Molecular Diagnostics, Regional Cancer Centre, Thiruvananthapuram, India.
- 5Division of Molecular Medicine, St. John's Research Institute, St John's Medical College, Bangalore, India.
- 6Research Department, Rajiv Gandhi Cancer Institute and Research, Delhi, India.
- 7Department of Pathology, DDRC SRL Diagnostics private limited, Thiruvananthapuram, India.
- 0Department of Cancer Research, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Alpha-fodrin (SPTAN1) promotes pancreatic cancer by interacting with CENP-E to regulate mitosis and aneuploidy. Its depletion enhances apoptosis and improves response to paclitaxel chemotherapy.
Area Of Science
- Molecular Biology
- Cancer Research
- Cell Biology
Background
- Alpha-fodrin (SPTAN1) is a scaffolding protein involved in various cellular functions.
- Previous studies indicated a role for alpha-fodrin in mitosis in glioblastoma.
- Pancreatic cancer is characterized by mitotic aberrations like aneuploidy and chromosome instability.
Purpose Of The Study
- To investigate the role of alpha-fodrin in pancreatic cancer progression and its relationship with CENP-E.
- To elucidate the molecular mechanisms underlying alpha-fodrin's function in pancreatic cancer.
- To assess the impact of alpha-fodrin on pancreatic cancer cell response to paclitaxel.
Main Methods
- Expression analysis of alpha-fodrin in pancreatic adenocarcinoma tissues.
- shRNA-mediated knockdown of alpha-fodrin in pancreatic cancer cells and xenograft models.
- Co-immunoprecipitation to study alpha-fodrin and CENP-E interaction.
- Analysis of aneuploidy, apoptosis markers (BCL2/BAX ratio, cytochrome C release), and MAPK pathway activation (JNK, ERK, P38).
- Correlation analysis between gene expression (SPTAN1, CENP-E) and patient survival.
Main Results
- Alpha-fodrin expression is elevated in pancreatic adenocarcinoma, suggesting a tumor-promoting role.
- Knockdown of alpha-fodrin significantly inhibits xenograft tumor growth.
- Alpha-fodrin interacts with CENP-E, recruiting it to the kinetochore and controlling aneuploidy.
- Alpha-fodrin depletion enhances paclitaxel-induced apoptosis via increased MAPK activation and altered BCL2/BAX ratios.
- Low expression of SPTAN1 and CENP-E correlates with improved patient survival.
Conclusions
- The alpha-fodrin-CENP-E axis is a key regulator of pancreatic cancer progression.
- Alpha-fodrin plays a critical role in maintaining chromosomal stability during mitosis.
- Targeting alpha-fodrin may enhance the efficacy of chemotherapeutic agents like paclitaxel in pancreatic cancer treatment.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

